Hydralazine Hydrochloride NDC 71335-0202

Product information

Brand name (proprietary)

Hydralazine Hydrochloride

Generic name (nonproprietary)

hydralazine hydrochloride

Active ingredients

Hydralazine hydrochloride — 25 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 040901

Marketing start

Jan 1, 2010

Listing expires

Dec 31, 2027

Other FDA classes

Arteriolar Vasodilation (Physiologic effect)

Identifiers

Product ID 71335-0202_c5e1b932-1ee1-4bf1-8e92-b70412c628feSPL ID c5e1b932-1ee1-4bf1-8e92-b70412c628feSPL set ID d2d98842-ff32-4a61-94e0-60e06919948fRxCUI 905222, 905225UNII FD171B778Y

Pharmacologic class

Arteriolar Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335020201 followed by a unit qualifier and the quantity Copy

Package 71335-0202-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 040901

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.